BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs7903146
,
DRD2
,
Apoptosis
,
Pseudomonas infection
,
Intestine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
chronic angle- closure glaucoma
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for chronic angle- closure glaucoma
Explore Curated Studies Results
Literature
Most Relevant Literature
Efficacy of goniosynechialysis for advanced chronic angle-closure glaucoma.
Chronic angle-closure glaucoma related to paroxetine treatment.
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma w…
Intraocular Pressure-reducing Effects of Latanoprost Versus Timolol in Chinese Patients With Chronic…
Patterns of damage in chronic angle-closure glaucoma compared to primary open-angle glaucoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma
Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chr…
A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in P…
Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ